12Mar/14

Investigation Report on China Tacrolimus Market, 2009-2018 – PR Newswire (press release)

Investigation Report on China Tacrolimus Market, 2009-2018
PR Newswire (press release)
Tacrolimus, also named as “”FK506″” and “”FR-900506″”, was developed by Fujisawa Pharmaceutical Co., Ltd. (later became Astellas Pharma by merging with Yamanouchi Pharmaceutical Co., Ltd.). In June 1993, it was firstly approved to Japan with the trade …

and more »

12Mar/14

Lupus Patient Makes Antibodies To Fight HIV – Huffington Post


Vaccine News Daily

Lupus Patient Makes Antibodies To Fight HIV
Huffington Post
“We found that the patient did indeed make these important antibodies, and by determining how this immune response occurred, we have enhanced our understanding of the process involved,” said study researcher Dr. Barton Haynes, director of the Duke 
Unique Individual Demonstrates Desired Immune Response to HIV VirusHealthCanal.com
Seattle BioMed receives $9.8 million grant for HIV vaccineVaccine News Daily

all 3 news articles »

12Mar/14

Interleukin-Antagonisten: Hoch effektiv gegen Entzündungen – Pharmazeutische Zeitung online

Interleukin-Antagonisten: Hoch effektiv gegen Entzündungen
Pharmazeutische Zeitung online
eines Transplantats innerhalb der ersten zehn Tage nach der Operation sind vor allem die zytotoxischen T-Lymphozyten verantwortlich. In Kombination mit anderen Immunsuppressiva soll Basiliximab die Abstoßung einer transplantierten Niere verhindern.

and more »